Login / Signup

Peyronie's disease response to intralesional collagenase clostridium histolyticum therapy is independent of baseline testosterone.

Douglas SchneiderMitchell O'LearyEliad AminiJake MillerNick HassasJeanie NguyenMuhammed A Moukhtar HammadDavid BarhamFaysal A Yafi
Published in: Andrology (2023)
Neither total testosterone nor hypogonadism is associated with a degree of improvement after collagenase clostridium histolyticum treatment.
Keyphrases
  • replacement therapy
  • smoking cessation
  • mesenchymal stem cells
  • bone marrow
  • cell therapy